Pertussis with severe pulmonary hypertension and leukocytosis treated with extracorporeal membrane oxygenation
Authors:
- 4 June 2005
- journal article
- case report
- Published by Springer Nature in Pediatric Surgery International
- Vol. 21 (8) , 692-694
Abstract
Pertussis, or “whooping cough,” is a highly communicable disease caused by the coccobacillus Bordetella pertussis. Pertussis remains one of the most common causes of death from infectious diseases worldwide. We describe a 5-week-old infant girl who presented with severe pertussis infection associated with extreme leukocytosis and required prolonged extracorporeal membrane oxygenation (ECMO). Nitric oxide therapy resolved the pulmonary hypertension, and she was successfully weaned from ECMO and discharged home after 3 months. We report successful application of ECMO for severe pertussis-induced respiratory failure despite multiple grave prognostic indicators (<1 year age, leukocytosis, pulmonary hypertension) and discuss the role of extracorporeal life support in treating pertussis.Keywords
This publication has 7 references indexed in Scilit:
- Pertussis—a re-emerging infection?Journal of Infection, 2004
- Fatal Pulmonary Hypertension Associated With Pertussis in Infants: Does Extracorporeal Membrane Oxygenation Have a Role?Pediatrics, 2003
- Pertussis of adults and infantsThe Lancet Infectious Diseases, 2002
- Neonatal pertussis requiring extracorporeal membrane oxygenationPediatric Surgery International, 2001
- Is leukocytosis a predictor of mortality in severe pertussis infection?Intensive Care Medicine, 2000
- Bordetella pertussis Infection: Pathogenesis, Diagnosis, Management, and the Role of Protective ImmunityEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulinThe Pediatric Infectious Disease Journal, 1999